- Home
- AUTL vs WSBF Comparison
AUTL vs WSBF Comparison
Compare AUTL & WSBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUTL | WSBF |
|---|---|---|
| Founded | 2014 | 1921 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.2M | 336.7M |
| IPO Year | 2025 | 2013 |
Fundamental Metrics
Financial Performance| Metric | AUTL | WSBF |
|---|---|---|
| Price | $1.70 | $18.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 51.7K |
| Earning Date | 05-14-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.79% |
| EPS Growth | N/A | ★ 46.53 |
| EPS | N/A | ★ 0.34 |
| Revenue | ★ $10,120,000.00 | N/A |
| Revenue This Year | $80.32 | N/A |
| Revenue Next Year | $53.96 | N/A |
| P/E Ratio | ★ N/A | $54.68 |
| Revenue Growth | ★ 496.00 | N/A |
| 52 Week Low | $1.18 | $12.71 |
| 52 Week High | $2.70 | $18.88 |
Technical Indicators
Market Signals| Indicator | AUTL | WSBF |
|---|---|---|
| Relative Strength Index (RSI) | 55.36 | 56.87 |
| Support Level | $1.27 | $17.69 |
| Resistance Level | $1.73 | $18.62 |
| Average True Range (ATR) | 0.13 | 0.39 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 49.03 | 83.92 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
About WSBF Waterstone Financial Inc. (MD)
Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The majority of its revenue comes from the Community Banking segment.